Judgment of the General Court (Seventh Chamber) of 16 May 2019 (Extracts)

GMP-Orphan (GMPO) v European Commission

Medicinal products for human use – Article 3(1)(b) of Regulation (EC) No 141/2000 – Definition of ‘significant benefit’ – Availability of orphan medicinal products – Article 5(12)(b) of Regulation No 141/2000 – Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products – Error of assessment – Error of law – Legitimate expectations

Case T-733/17

Reports of Cases

not yet published (Court Reports - general) - publication in extract form

• (Appeal Case before the Court of Justice C-575/19 P)

Order of the President of the General Court of 23 November 2018

GMP-Orphan (GMPO) v European Commission

Interim relief — Medicinal products for human use — Active substance trientine tetrahydrochloride — Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product — Regulation (EC) No 141/2000 — Application for suspension of operation of a measure — Lack of urgency

Case T-733/17 R

Reports of Cases

published in the electronic Reports of Cases (Court Reports - general - 'Information on unpublished decisions' section)